Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-016342
Filing Date
2022-03-04
Accepted
2022-03-04 16:56:10
Documents
2
Period of Report
2022-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2198
2 POA DOCUMENT poa.txt EX-24 3948
  Complete submission text file 0001209191-22-016342.txt   7564
Mailing Address INSPIRE PHARMACEUTICALS, INC., 4222 EMPEROR BLVD., STE. 470 DURHAM NC 27703-8466
Business Address
YERXA BENJAMIN R (Reporting) CIK: 0001145910 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 22714935

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations